Your browser doesn't support javascript.
loading
A phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy.
Armstrong, A J; Halabi, S; Healy, P; Lee, W R; Koontz, B F; Moul, J W; Mundy, K; Creel, P; Wood, S; Davis, K; Carducci, M A; Stein, M; Hobbs, C; Reimer, B; Nguyen, M; Anand, M; Bratt, L; Kim, S; Tran, P T; George, D J.
Afiliação
  • Armstrong AJ; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Halabi S; Division of Urology, Department of Surgery, Duke University, Durham, NC, USA.
  • Healy P; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Lee WR; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Koontz BF; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Moul JW; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Mundy K; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Creel P; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Wood S; Department of Radiation Oncology, Duke University, Durham, NC, USA.
  • Davis K; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Carducci MA; Department of Radiation Oncology, Duke University, Durham, NC, USA.
  • Stein M; Division of Urology, Department of Surgery, Duke University, Durham, NC, USA.
  • Hobbs C; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Reimer B; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Nguyen M; Duke Cancer Institute, Duke University, Durham, NC, USA.
  • Anand M; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Bratt L; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Kim S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Tran PT; Rutgers Cancer Institute of NJ, New Brunswick, NJ, USA.
  • George DJ; Duke Cancer Institute, Duke University, Durham, NC, USA.
Prostate Cancer Prostatic Dis ; 19(1): 100-6, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26754260
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pirróis / Prednisona / Taxoides / Indóis / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pirróis / Prednisona / Taxoides / Indóis / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos